title: International adaptations of NCCN Clinical Practice Guidelines in Oncology.
abstract: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) are evidence- and consensus-based clinical practice guidelines addressing malignancies that affect more than 97% of all patients with cancer in the United States. The NCCN Guidelines are used extensively in the United States and globally. Use of the guidelines outside the United States has driven the need to adapt the guidelines based on local, regional, or national resources. The NCCN Guidelines Panels created, vetted, and continually update the NCCN Guidelines based on published scientific data on cancer detection, diagnosis, and treatment efficacy. The guidelines are developed within the context of commonly available resources, methods of payment, societal and cultural expectations, and governmental regulations as they exist in the United States. Although many of the cancer management recommendations contained in the NCCN Guidelines apply broadly from a global perspective, not all do. Disparities in availability and access to health care exist among countries, within countries, and among different social groups in the same country, especially regarding resources for cancer prevention, early detection, and treatment. In addition, different drug approval and payment processes result in regional variation in availability of and access to cancer treatment, especially highly expensive agents and radiation therapy. Differences in cancer risk, predictive biomarker expression, and pharmacogenetics exist across ethnic and racial groups, and therefore across geographic locations. Cultural and societal expectations and requirements may also require modification of NCCN Guidelines for use outside the United States. This article describes the adaptation process, using the recent Latin American adaptation of the 2013 NCCN Guidelines for Colorectal Cancer as an example.
authors.affiliation: From aNational Comprehensive Cancer Network, Fort Washington, Pennsylvania; bFox Chase Cancer Center, Philadelphia, Pennsylvania; cUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; dRobert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; and eUniversity of Washington/Seattle Cancer Care Alliance, Seattle, Washington.
authors.forename: Robert W
authors.initials: RW
authors.lastname: Carlson
authors.forename: Jonathan K
authors.initials: JK
authors.lastname: Larsen
authors.forename: Joan
authors.initials: J
authors.lastname: McClure
authors.forename: C Lyn
authors.initials: CL
authors.lastname: Fitzgerald
authors.forename: Alan P
authors.initials: AP
authors.lastname: Venook
authors.forename: Al B
authors.initials: AB
authors.lastname: Benson
authors.forename: Benjamin O
authors.initials: BO
authors.lastname: Anderson
mesh_terms: D014943:Global Health; D006801:Humans; D009369:Neoplasms; D017410:Practice Guidelines as Topic; D014481:United States